Treatment of Metastatic Renal Cell Carcinoma
dc.contributor.author | Richter I. | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.date.accessioned | 2020-06-08T09:38:53Z | |
dc.date.available | 20-28-2019 | en |
dc.date.available | 2020-06-08T09:38:53Z | |
dc.date.issued | 2018 | cs |
dc.date.updated | 29-22-2019 | en |
dc.format.extent | 7 | cs |
dc.identifier.doi | 10.14735/amko2018110 | |
dc.identifier.issn | 0862-495X | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/155559 | |
dc.language.iso | cze | cs |
dc.publisher | Ambit Media, a.s. | cs |
dc.publisher.city | Praha | cs |
dc.relation.ispartof | Klinicka Onkologie | en |
dc.relation.ispartofseries | 1 | cs |
dc.subject | renal cancer | cs |
dc.subject | targeted therapy | cs |
dc.subject | immunotherapy | cs |
dc.subject | metastases | cs |
dc.subject | biomarkers | cs |
dc.title | Treatment of Metastatic Renal Cell Carcinoma | en |
dc.title | Úvod do problematiky léčby zhoubných nádoru ledvin | cs |
local.citation.epage | 110-116 | cs |
local.citation.spage | 110-116 | cs |
local.identifier.publikace | 6163 | |
local.relation.issue | 2 | cs |